Richard A. Paulson - 04 Nov 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Issuer symbol
KPTI
Transactions as of
04 Nov 2022
Net transactions value
-$15,858
Form type
4
Filing time
08 Nov 2022, 17:19:48 UTC
Previous filing
05 Oct 2022
Next filing
06 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $15,858 -3,493 -0.56% $4.54 616,017 04 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.